Our patients are at the core of what we do. Because of this, we would like to express our appreciation for the patients who have previously participated or are currently enrolled in our clinical trials.

Our current clinical trials

We’re actively recruiting patients to participate in clinical trials to evaluate our therapeutic candidates.

IO102-IO103 + nivolumab in metastatic melanoma

Expanded Access Policy